Aroclor 1016 Quickview (CASRN 12674-11-2)

Health assessment information on a chemical substance is included in IRIS only after a comprehensive review of toxicity data by U.S. EPA health scientists from several Program Offices, Regional Offices, and the Office of Research and Development.

Disclaimer: This QuickView represents a snapshot of key information. We suggest that you read the IRIS Summary to put this information into complete context.

For definitions of terms in the IRIS Web site, refer to the IRIS Glossary.

Status of Data for Aroclor 1016

File First On-Line: 01/01/1993; Last Significant Revision: 01/01/1993

Category (section)	Status	Last Revised
Oral RfD Assessment	On-line	11/01/1996
Inhalation RfC Assessment	No data
Carcinogenicity Assessment	No data

Synonyms

12674-11-2
Aroclor 1016

HSDB 6352

Aroclor 1016 Source Documents

Aroclor 1016 Summary

Revision History

Date	Section	Description
04/01/1997	III., IV., V.	Supplementary Data were removed from IRIS on or before April 1997. IRIS users were directed to the appropriate EPA Program Offices for this information.

See IRIS Summary for complete revision history.

Chronic Health Hazard Assessments for Noncarcinogenic Effects

Reference Dose for Chronic Oral Exposure (RfD)

Critical Effect	Point of Departure*	UF	MF	RfD
Reduced birth weights	NOAEL : 0.007 mg/kg-day	100	1	7 x10^-5 mg/kg-day

* The Point of Departure listed serves as a basis from which the Oral RfD was derived. See Discussion of Conversion Factors and Assumptions for more details.

Principal and Supporting Studies (Oral RfD)
- Monkey reproductive bioassay, Barsotti and van Miller, 1984; Levin et al., 1988; Schantz et al., 1989, 1991
Confidence in the Oral RfD
- Study -- Medium
- Database -- Medium
- RfD -- Medium

Top of page

Reference Concentration for Chronic Inhalation Exposure (RfC)

Not Assessed under the IRIS Program.

Top of page